Budapest, Hungary

Emese Csuzdi

This inventor holds 3 USPTO granted patents. Top assignees: Egis Gyogyszergyar Rt., Gyogyszerkutato Intezet Kft., Schering Aktiengesellschaft. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emese Csuzdi. Retrieved from https://idiyas.com/inventor/emese-csuzdi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emese Csuzdi: Innovator in Benzodiazepine Derivatives

Introduction

Emese Csuzdi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of benzodiazepine derivatives. With a total of 3 patents to his name, Csuzdi's work has implications for various therapeutic applications.

Latest Patents

Among his latest patents are innovative compounds related to 2,3-benzodiazepine derivatives. These include a patent for "2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors," which focuses on a compound of formula I. His research in this area highlights the potential for new treatments in neurological disorders.

Career Highlights

Throughout his career, Emese Csuzdi has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Schering Aktiengesellschaft and Egis Gyogyszergyar Rt. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Emese has collaborated with esteemed colleagues, including István Ling and Gizella Ábrahám. Their joint efforts have further advanced the research and development of benzodiazepine derivatives.

Conclusion

Emese Csuzdi's contributions to the field of pharmaceuticals, particularly through his patents on benzodiazepine derivatives, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…